Press Release

Feb, 01 2023

Koninklijke Philips N.V., Canon Medical Systems ANZ Pty Limited, and General Electric Company dominated the Global Uterine Cancer Diagnostics Market in 2022

The Global Uterine Cancer Diagnostics Market is expected to grow with a CAGR of 10.7% in the forecast period of 2023 to 2030. The years considered for the study are as mentioned below.

Access Full Report @

The global uterine cancer diagnostics market is a highly consolidated market, which includes a specific number of key players. The market has witnessed increased strategic developments owing to favorable market scenarios.

The major players dealing in the global uterine cancer diagnostics market are introducing a strong range of products and services and adopting strategic initiatives such as acquisition, agreement, business expansion, announcement, achievement, and innovation into the market. This helped companies to maximize sales with an enhanced services portfolio.

For instance;

  • In November 2022, Koninklijke Philips N.V., announced the global launch of a next-generation compact portable ultrasound solution at the Radiological Society of North America (RSNA) annual meeting to bring the diagnostic quality associated with premium cart-based ultrasound systems to more patients. It is portable and versatile with good image quality or performance. It is compatible with Philips ultrasound systems Affiniti and EPIQ transducer. This has helped the company to expand its product portfolio

Koninklijke Philips N.V. is the market leader in the global uterine cancer diagnostics market globally. Some of the other players in this market are Canon Medical Systems ANZ Pty Limited., General Electric Company, Siemens Healthcare Private Limited, FUJIFILM Corporation, Medtronic, F-Hoffmann La Roche Ltd., GRAIL, Olympus Corporation, B. Braun Melsungen AG, ESAOTE SPA, Stryker, Guzip Biomarkers Corporation, Arquer Diagnostics Ltd, KARL STORZ, Narang Medical Limited, AED, Integra LifeSciences, Jalal Surgical, and Surtex Instruments Limited.

Koninklijke Philips N.V.

Koninklijke Philips N.V. is headquartered in Amsterdam, the Netherlands, and was founded in 1891. The company focuses on the purpose of improving people’s health and well-being through meaningful innovation and giving clinicians the tools they need to make a precision diagnosis and deliver personalized treatment. The company operates various business segments such as diagnosis & treatment businesses, connected care businesses, personal health businesses, and others, where diagnosis & treatment businesses is the market-focused business segment. The company offers various products categories such as breathing and respiratory care, circular edition systems, computed tomography machines & solutions, customer service solutions, diagnostic ECG, diagnostic informatics, emergency care and resuscitation solutions, enterprise telehealth portfolio, hospital respiratory care, image guided therapy, mother & child care, MRI systems & solutions, neurology, oncology, pathology, patient monitoring, personal health programs, radiation oncology, radiography, X-ray & fluoroscopy solutions, sleep, supplies and accessories, ultrasound, and ventilation, where ultrasound is the market focused product category.

The company has a presence in Europe, Asia-Pacific, Americas, and the Middle East and Africa.

For instance;

  • In April 2019, Koninklijke Philips N.V., and Hong Duc General Hospital in Ho Chi Minh City, Vietnam, announced a seven-year partnership agreement covering a comprehensive turnkey solution for high-quality general healthcare services. Philips will provide them latest medical imaging, patient monitoring, and healthcare IT solutions. The MR-HIFU solution at Hong Duc General Hospital II has provided a non-invasive alternative to the traditional surgical treatment of uterine fibroids. This has helped the company to advance its technology for uterine cancer patients

Canon Medical Systems ANZ Pty Limited.

Canon Medical Systems ANZ Pty Limited is headquartered Otawara-shi, Japan, and was founded in 2016. The company focuses on sales, marketing, procurement, warehousing, and distribution, including spare parts of medical diagnostic imaging equipment for X-Ray, angiography, CT, and patient monitoring among others. The company offers various product categories such as angiography, computed tomography, magnetic resonance, ultrasound, X-ray, molecular imaging, healthcare IT, and other medical devices, where computed tomography, magnetic resonance, and ultrasound are the market-focused product categories.

The company has a presence in Asia-Pacific.

For instance;

  • In November 2022, Canon Inc., the parent company of Canon Medical Systems Anz Pty Limited, announced that the company decided to establish a new subsidiary, to be named Canon Healthcare USA, INC. By strengthening its presence in the highly influential American medical market, Canon aims to accelerate the growth of its medical business. This has helped the company to expand its business in other regions

Uterine Cancer Diagnostics Market

General Electric Company

General Electric Company is headquartered in Boston, U.S., and was founded in 1892. The company focuses on digitizing healthcare to improve the lives of patients and create meaningful efficiencies for providers, health systems, and researchers around the world. The company offers various product categories such as imaging, ultrasound, anesthesia delivery, diagnostic ECG, maternal & infant care, patient monitoring, ventilators, pharmaceutical imaging agents, digital solutions, refurbished systems, parts and accessories where imaging and ultrasound are the market-focused product categories.

The company has a presence in North America, Europe, Asia-Pacific, South America, the Middle East and Africa.

For instance,

  • In October 2022, General Electric Company collaborated with several research institutes such as the University of Cambridge Hospitals, Sophia Genetics, and earlier with Optellum to use imaging data in collaboration with Artificial intelligence. This will help to reduce the diagnosing time of several cancers and help to provide personalized care to patients. This has helped the company to widen its horizons in cancer diagnostics.

Client Testimonials